The effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy—the IRON-CRT trial

Autor: Pieter Martens, W.H. Wilson Tang, Paul Dendale, Pieter M. Vandervoort, Liesbeth Bruckers, Petra Nijst, Lieven Herbots, Wilfried Mullens, Jeroen Dauw, Matthias Dupont
Přispěvatelé: Bruckers, Liesbeth/0000-0002-6978-3002, Martens, Pieter/0000-0002-6036-2113, Dauw, Jeroen/0000-0003-4605-3450
Rok vydání: 2021
Předmět:
Zdroj: European Heart Journal. 42:4905-4914
ISSN: 1522-9645
0195-668X
DOI: 10.1093/eurheartj/ehab411
Popis: Aims Iron deficiency is common in heart failure with reduced ejection fraction (HFrEF) and negatively affects cardiac function and structure. The study the effect of ferric carboxymaltose (FCM) on cardiac reverse remodelling and contractile status in HFrEF. Methods and results Symptomatic HFrEF patients with iron deficiency and a persistently reduced left ventricular ejection fraction (LVEF Conclusions Treatment with FCM in HFrEF patients with iron deficiency and persistently reduced LVEF after CRT results in an improvement of cardiac function measured by LVEF, LVESV, and cardiac force–frequency relationship.
Databáze: OpenAIRE